C1 ESTERASE INHIBITOR [C1-INH] DEFICIENCY

Clinical trials for C1 ESTERASE INHIBITOR [C1-INH] DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new C1 ESTERASE INHIBITOR [C1-INH] DEFICIENCY trials appear

Sign up with your email to follow new studies for C1 ESTERASE INHIBITOR [C1-INH] DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New pill shows promise for rapid relief from rare, painful swelling attacks

Symptom relief Completed

This completed Phase 3 trial tested whether an oral capsule called deucrictibant could safely and quickly relieve sudden swelling attacks in people with hereditary angioedema (HAE). The study involved 134 participants aged 12 to 75 who took either the study drug or a placebo pill…

Matched conditions: C1 ESTERASE INHIBITOR [C1-INH] DEFICIENCY

Phase: PHASE3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief

Last updated Mar 30, 2026 14:32 UTC

C1 ESTERASE INHIBITOR [C1-INH] DEFICIENCY

Get alerted when new C1 ESTERASE INHIBITOR [C1-INH] DEFICIENCY trials appear

New pill shows promise for rapid relief from rare, painful swelling attacks